Andhra Pradesh allots 531.77 acres of land to Laurus Labs

Published On 2025-07-28 06:00 GMT   |   Update On 2025-07-28 06:00 GMT
Advertisement

Andhra Pradesh: Laurus Labs has received a major boost for its expansion plans with the Government of Andhra Pradesh allotting 531.77 acres of land to the company in the IP Rambilli Phase-II of Anakapalli District.

The land will be used to establish the Laurus Pharma Zone (LPZ), which will house manufacturing units for pharmaceutical products.

"The Government of Andhra Pradesh has issued G.O.Ms.No.136 dated July 27, 2025 to this extent for allotment of land to the Company," Laurus stated in a BSE filing.

The Company has projected 5,630 Crores of investment and to provide employment to 6,350 people in three phases over a period of eight years.

With this allotment, the Company has secured an important component for future expansion of its business i.e., land parcel.

In March, Medical Dialogues team reported that the company had approved an investment of Rs 83 crore in KRKA Pharma, a joint venture of the Company. 

Advertisement

Read also: Laurus Lab Gets CDSCO Panel Nod To Manufacture and Market Sodium Phenylbutyrate Powder

Laurus Labs is an Indian pharmaceutical company headquartered in Hyderabad. The Company's major focus areas include anti-retroviral, Hepatitis C, and Oncology drugs.

Most of the Laurus Labs manufacturing facilities are approved by major regulatory authorities USFDA, WHO-Geneva, UK-MHRA, etc. 

Read also: Aurobindo Pharma, Dr Reddy's Labs and 4 others partner with Telangana to set up facilities in Pharma City

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News